Pradipkumar Pharma Profile
Key Indicators
- Authorised Capital ₹ 9.00 Cr
- Paid Up Capital ₹ 9.00 Cr
- Company Age 33 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 10.00 Cr
- Satisfied Charges ₹ 11.00 Cr
- Revenue Growth -27.91%
- Profit Growth -64.13%
- Ebitda -80.13%
- Net Worth 8.06%
- Total Assets -21.99%
About Pradipkumar Pharma
Pradipkumar Pharma Private Limited (PPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 26 August 1991 and has a history of 33 years and five months. Its registered office is in Mumbai, Maharashtra, India.
The Corporate was formerly known as Pradipkumar And Company Pharma Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 9.00 Cr and a paid-up capital of Rs 9.00 Cr.
The company currently has active open charges totaling ₹10.00 Cr. The company has closed loans amounting to ₹11.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Pradipkumar Shah, Umesh Shah, Dinesh Shah, and One other member serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U99999MH1991PTC063069
-
Company No.
063069
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
26 Aug 1991
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Pradipkumar Pharma?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pradipkumar Shah
|
Managing Director | 26-Aug-1991 | Current |
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Dhiren Shah
|
Director | 01-Apr-1995 | Current |
|
Umesh Shah
|
Whole-Time Director | 01-Apr-1995 | Current |
|
Dinesh Shah
|
Whole-Time Director | 01-Apr-1995 | Current |
Financial Performance of Pradipkumar Pharma.
Pradipkumar Pharma Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 27.91% decrease. The company also saw a substantial fall in profitability, with a 64.13% decrease in profit. The company's net worth moved up by a moderate rise of 8.06%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pradipkumar Pharma?
In 2023, Pradipkumar Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹10.00 Cr
₹11.00 Cr
Charges Breakdown by Lending Institutions
- Citi Bank N.A. : 10.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 09 Mar 2016 | Citi Bank N.A. | ₹10.00 Cr | Open |
| 19 May 2006 | Bank Of India | ₹2.00 Cr | Satisfied |
| 21 Feb 1995 | Bank Of India | ₹9.00 Cr | Satisfied |
How Many Employees Work at Pradipkumar Pharma?
Unlock and access historical data on people associated with Pradipkumar Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pradipkumar Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pradipkumar Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.